final results lithium trial

Despite promising results from an Italian pilot study, follow-up trials of lithium in ALS have failed to show any benefits for the drug

posted on April 12, 2010 - 8:15pm
An MDA-supported, 10-center trial of more than 100 people with amyotrophic lateral sclerosis (ALS) who took the oral medication lithium carbonate — some in conjunction with the ALS drug riluzole — has shown the drug does not provide benefit for disease progression or survival. The study also showed that lithium can have concerning side effects, and when taken alone (without riluzole),...

New content is being added every day. Please check back again.